Webinar
Digital health is a hot topic anticipated to transform healthcare. The mechanisms to fund and pay for digital health solutions are in many countries not as developed as the traditional pathways for drugs, medical devices and hospital care. France is one of the few countries who has create a specific pathway to establish reimbursement for digital health solution. In this webinar, Michel Verhasselt who has been working with this new pathway throughout the development process and then once released has been able to successfully establish reimbursement for new technologies.
Speaker
Michel Verhasselt CEO and founder of Meditech Access, which he founded 2012. He holds a master's degree in business administration and health economics from the Catholic University of Lille. He has 25 years experience in the field of health economics, HTA, DRG coding and reimbursement, especially for the medical device industry, make him an expert. He conducts public affairs and market access activities for France, Belgium and Switzerland.
Audrey Ortiz started her training as an engineer, in preparatory class for “Grandes Ecoles” and ended up earning a PharmD and a Master Degree in Health Economics from Paris-Dauphine University. She has work experience at large pharmaceutical firms (Sanofi and
Roche) and mid-sized ones (Celgene and Hospira). Determined to further develop her skills in the MedTech field after an empowering experience at Synergus, she joined MediTech Access, a consulting company highly specialized in Market Access and Health Economics in France, Belgium and Switzerland. Recruited as a consultant, she quickly became Manager and Partner. She is currently responsible for managing projects in France, leading the activities
in Belgium and Switzerland and for developing the European activities. For the past five years, she has been successfully managing the funding and the reimbursement of implants and invasive devices in Belgium.